Cite
Antibiotherapy at birth in very low birth weight infants before and after the use of interleukin 6 as an infectious biomarker in a tertiary level unit
MLA
Marta Costa-Romero, et al. “Antibiotherapy at Birth in Very Low Birth Weight Infants before and after the Use of Interleukin 6 as an Infectious Biomarker in a Tertiary Level Unit.” Boletin Medico Del Hospital Infantil de Mexico, vol. 78, no. 6, Oct. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....97f4fa5202ef9cdbfc9fefeb039f1471&authtype=sso&custid=ns315887.
APA
Marta Costa-Romero, María Caunedo-Jiménez, Gonzalo Solís-Sánchez, Sonia Lareu-Vidal, Belén Fernández Colomer, & Silvia Martín-Ramos. (2021). Antibiotherapy at birth in very low birth weight infants before and after the use of interleukin 6 as an infectious biomarker in a tertiary level unit. Boletin Medico Del Hospital Infantil de Mexico, 78(6).
Chicago
Marta Costa-Romero, María Caunedo-Jiménez, Gonzalo Solís-Sánchez, Sonia Lareu-Vidal, Belén Fernández Colomer, and Silvia Martín-Ramos. 2021. “Antibiotherapy at Birth in Very Low Birth Weight Infants before and after the Use of Interleukin 6 as an Infectious Biomarker in a Tertiary Level Unit.” Boletin Medico Del Hospital Infantil de Mexico 78 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....97f4fa5202ef9cdbfc9fefeb039f1471&authtype=sso&custid=ns315887.